Earnings History Data for Nuvation Bio (NUVB) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Nuvation Bio
Nuvation Bio Inc. is a biopharmaceutical company. It engages in developing differentiated and novel therapeutic candidates for unmet needs in oncology. Nuvation Bio Inc., formerly known as Panacea Acquisition Corp., is based in NEW YORK.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 29-02-2024 | PM | NUVB | Nuvation Bio | 436.00 | -0.06 | -0.10 | 0.00 | Nuvation Bio GAAP EPS of -$0.06 [3/1/2024 3:28 AM] |
2.22 | 0.35 (18.72%) |
1.87 | 0.0 (0.00%) |
0.95 - 2.34 | 2,192,630 | 680,000 | 14,365 | ||
| 04-05-2023 | AH | 4:05 PM ET (May 4) |
NUVB | Nuvation Bio | 354.00 | -0.10 | -0.09 | 0.00 | Nuvation Bio GAAP EPS of -$0.10 [5/4/2023 5:53 PM] |
1.69 | 0.07 (4.32%) |
1.63 | 0.01 (0.62%) |
1.52 - 4.98 | 234,374 | 370,000 | 9,024 | |
| 15-03-2023 | AH | 4:05 PM ET (Mar 15) |
NUVB | Nuvation Bio | 349.00 | -0.10 | -0.10 | 0.00 | Nuvation Bio GAAP EPS of -$0.10 beats by $0.02 [3/15/2023 5:09 PM] |
1.69 | 0.05 (2.74%) |
1.70 | 0.06 (3.66%) |
1.54 - 6.02 | 850,923 | 620,000 | 131,539 | |
| 03-11-2022 | AH | 4:05 PM ET (Nov 3) |
NUVB | Nuvation Bio | 506.00 | -0.12 | -0.14 | 0.00 | Nuvation Bio GAAP EPS of -$0.12 beats by $0.02 [11/3/2022 5:25 PM] |
2.08 | -0.06 (-2.80%) |
2.14 | 0.0 (0.00%) |
1.92 - 10.45 | 244,349 | 370,000 | 5,631 | |
| 04-08-2022 | AH | NUVB | Nuvation Bio | 502.00 | -0.16 | -0.13 | 0.00 | 2.49 | 0.12 (5.06%) |
2.49 | 0.0 (0.00%) |
2.25 - 10.45 | 1,513,694 | 1,310,000 | 775 | |||
|
|
||||||||||||||||||
| 09-05-2022 | AH | NUVB | Nuvation Bio | 1,045 | -0.10 | -0.15 | 0.00 | Nuvation Bio GAAP EPS of -$0.10 beats by $0.04 [5/9/2022 5:27 PM] |
4.44 | 0.21 (4.96%) |
4.23 | 0.0 (0.00%) |
4.16 - 15.23 | 628,779 | 911,416 | 3,329 | ||
| 10-11-2021 | AH | NUVB | Nuvation Bio | 1,912 | -0.11 | -0.11 | 0.00 | Nuvation Bio reports Q3 results [11/10/2021 5:18 PM] |
9.10 | 0.37 (4.24%) |
8.86 | 0.13 (1.49%) |
7.66 - 15.23 | 340,267 | 970,000 | 201 | ||
| 12-08-2021 | AH | NUVB | Nuvation Bio Inc. | 1,804 | -0.09 | -0.11 | 0.00 | 9.19 | 0.33 (3.72%) |
8.86 | 0.0 (0.00%) |
7.86 - 15.23 | 559,122 | 250,000 | 3,991 | |||
| 17-05-2021 | AH | NUVB | Nuvation Bio Inc. | 2,388 | -0.12 | -0.08 | 0.00 | Nuvation Bio reports Q1 results [5/17/2021 5:09 PM] |
12.00 | 0.09 (0.76%) |
11.91 | 0.0 (0.00%) |
8.56 - 15.07 | 760,829 | 390,000 | 81,961 | ||